---
figid: PMC2323406__pcbi.0040030.g004
figlink: /pmc/articles/PMC2323406/figure/pcbi-0040030-g004/
number: Figure 4
caption: 'This schematic shows the major steps in EGFR signaling. At the top of the
  pathway ligand binds to the receptor and induces receptor dimerization and activation.
  The signal is then transduced through a series of adaptor proteins SHC, GRB2, and
  SOS, which in turn activates the MAPK cascade RAF, MEK and ERK. There are two negative
  feedback loops: internalization and degradation of the receptor complex, and ERK
  deactivation of SOS.'
pmcid: PMC2323406
papertitle: Stimulus Design for Model Selection and Validation in Cell Signaling .
reftext: Joshua F Apgar, et al. PLoS Comput Biol. 2008 Feb;4(2):e30.
pmc_ranked_result_index: '40386'
pathway_score: 0.93227
filename: pcbi.0040030.g004.jpg
figtitle: 'Stimulus Design for Model Selection and Validation in Cell Signaling '
year: '2008'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2323406__pcbi.0040030.g004.html
  '@type': Dataset
  description: 'This schematic shows the major steps in EGFR signaling. At the top
    of the pathway ligand binds to the receptor and induces receptor dimerization
    and activation. The signal is then transduced through a series of adaptor proteins
    SHC, GRB2, and SOS, which in turn activates the MAPK cascade RAF, MEK and ERK.
    There are two negative feedback loops: internalization and degradation of the
    receptor complex, and ERK deactivation of SOS.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK3
  - SHC1
  - MAPK1
  - SHC3
  - SOS2
  - NRAS
  - SOS1
  - EGFR
  - KRAS
  - RAF1
  - MAP2K1
  - SHC2
  - SHC4
  - ARAF
  - BRAF
  - GRB2
  - EGF
  - MAP2K2
  - HRAS
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: soS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: soS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: GRB2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
